Janssen-Cilag Farmaceutica Ltda. clinical trials

A country office of Johnson & Johnson

The registry lists 13 studies whose lead sponsor is Janssen-Cilag Farmaceutica Ltda.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 28, 2026.

Studies

Recruiting first, then most recently updated. Showing 13 of 13. All Johnson & Johnson studies →

• A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)Not yet recruitingNCT07680907

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• A Study to Characterize High-Risk Non-Muscle-Invasive Bladder Cancer Participants in PortugalRecruitingNCT07784387

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in PortugalCompletedNCT03666715

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1CompletedNCT04147325

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With DiethylstilbestrolCompletedNCT04268628

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Approved for marketingNCT02437019

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone PalmitateCompletedNCT01448720Phase 3

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl EstradiolCompletedNCT00307632Phase 4

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With RisperidoneCompletedNCT01010776Phase 4

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of LifeCompletedNCT00814658Phase 4

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00783835Phase 4

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)No longer availableNCT01026376

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.

• An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.CompletedNCT00307619Phase 3

  Sponsor listed in the registry: Janssen-Cilag Farmaceutica Ltda.